Drug Database
Back to search

Netherlands· NL-2ec104913270

Biktarvy 30 mg/120 mg/15 mg filmomhulde tabletten

A emtricitabine, tenofovir alafenamide and bictegravir product containing bictegravirnatrium + emtricitabine + tenofoviralafenamidefumaraat, registered in Netherlands by Gilead Sciences Ireland UC. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR20

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBiktarvy 30 mg/120 mg/15 mg filmomhul…ATCJ05AR20REGISTER NO.NL-2ec104913270PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bictegravirnatrium + emtricitabine + tenofoviralafenamidefumaraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine, tenofovir alafenamide and bictegravir is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR20 (emtricitabine, tenofovir alafenamide and bictegravir), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search emtricitabine, tenofovir alafenamide and bictegravir products by name

Emtricitabine, tenofovir alafenamide and bictegravir · ATC J05AR20

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BICTEGRAVIRNATRIUM + EMTRICITABINE + TENOFOVIRALAFENAMIDEFUMARAAT
Manufacturer
Gilead Sciences Ireland UC
Country
Netherlands (NL)
ATC code
J05AR20
ATC class
Emtricitabine, tenofovir alafenamide and bictegravir
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/18/1289

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J05AR20

Emtricitabine, tenofovir alafenamide and bictegravir, as other registers publish it.

All emtricitabine, tenofovir alafenamide and bictegravir products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d6c75fc5-e28c-466e-bd6c-95775875b458
GET /v1/drugs/d6c75fc5-e28c-466e-bd6c-95775875b458?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/biktarvy-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Emtricitabine, tenofovir alafenamide and bictegravir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp128499",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLYVINYLALCOHOL (E 1203)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "BICTEGRAVIRNATRIUM",
    "EMTRICITABINE",
    "TENOFOVIRALAFENAMIDEFUMARAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2022/11/21",
  "procedure_number": "EMEA/H/C/004449",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/18/1289",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about emtricitabine, tenofovir alafenamide and bictegravir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console